DESIGN THERAPEUTICS INC
DSGNNASDAQ🏆 #2650 by market capEarnings Nov 11US Equity
$10.78▼ $0.28 (−2.53%)
Latest quoteTrack DSGN
Get earnings, price moves & breaking news on Telegram
24h▼ 2.5%
7d▲ 5.5%
14d▲ 4.4%
30d▼ 14.3%
ytd▲ 14.9%
1y▲ 64.1%
🏦Market Cap
$675M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
DESIGN THERAPEUTICS INC
DSGNAnalyst Ratings
Price
$10.78
Total
7
Raised
3
Lowered
1
Avg PT
$23.50
H / L
$26 / $21
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Oppenheimer | Reiterated | Outperform | 2026-05-04 | $21.00 | +94.80% |
RBC Capital | Reiterated | Outperform | 2026-03-10 | $7.00 | −35.10% |
Leerink Partners | Upgraded | Market Perform → Outperform | 2025-12-03 | $14.00 | +29.90% |
Piper Sandler | Upgraded | Neutral → Overweight | 2024-05-07 | $20.00 | +85.50% |
Wedbush | Reiterated | Neutral | 2024-03-20 | — | — |
SVB Leerink | Downgraded | Outperform → Market Perform | 2023-08-15 | — | — |
Goldman Sachs | Upgraded | Sell → Neutral | 2023-05-04 | $10.00 | −7.20% |
Institution
Oppenheimer
Reiterated · Outperform · 2026-05-04
$21.00
+94.80%
RBC Capital
Reiterated · Outperform · 2026-03-10
$7.00
−35.10%
Leerink Partners
Upgraded · Market Perform → Outperform · 2025-12-03
$14.00
+29.90%
Piper Sandler
Upgraded · Neutral → Overweight · 2024-05-07
$20.00
+85.50%
Wedbush
Reiterated · Neutral · 2024-03-20
—
—
SVB Leerink
Downgraded · Outperform → Market Perform · 2023-08-15
—
—
Goldman Sachs
Upgraded · Sell → Neutral · 2023-05-04
$10.00
−7.20%
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space